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Background. The disruption of physiologic vascular smooth muscle cell (VSMC) migration initiates atherosclerosis development.
The biochemical mechanisms leading to dysfunctional VSMC motility remain unknown. Recently, cytokine BMP-2 has been
implicated in various vascular physiologic and pathologic processes. However, whether BMP-2 has any effect upon VSMCmotility,
or by what manner, has never been investigated. Methods. VSMCs were adenovirally transfected to genetically overexpress BMP-
2. VSMC motility was detected by modified Boyden chamber assay, confocal time-lapse video assay, and a colony wounding
assay. Gene chip array and RT-PCR were employed to identify genes potentially regulated by BMP-2. Western blot and real-
time PCR detected the expression of myosin Va and the phosphorylation of extracellular signal-regulated kinases 1/2 (Erk1/2).
Immunofluorescence analysis revealed myosin Va expression locale. Intracellular Ca2+ oscillations were recorded. Results. VSMC
migration was augmented in VSMCs overexpressing BMP-2 in a dose-dependent manner. siRNA-mediated knockdown of myosin
Va inhibitedVSMCmotility. BothmyosinVamRNA and protein expression significantly increased after BMP-2 administration and
were inhibited by Erk1/2 inhibitor U0126. BMP-2 induced Ca2+ oscillations, generated largely by a “cytosolic oscillator”.Conclusion.
BMP-2 significantly increased VSMCs migration and myosin Va expression, via the Erk signaling pathway and intracellular Ca2+
oscillations. We provide additional insight into the pathophysiology of atherosclerosis, and inhibition of BMP-2-induced myosin
Va expression may represent a potential therapeutic strategy.
1. Introduction
Recent studies demonstrate that BMP-2, a cytokine of the
transforming growth factor-𝛽 superfamily, plays an impor-
tant role in both physiological and pathophysiological vas-
cular development [1, 2]. Genetically manipulated BMP-2
deficient mice die between days 7 and 10 of life from cardiac
defects prior to bone formation, suggesting the significant
cardiovascular importance of BMP-2 [3]. Vascular smooth
muscle cells (VSMCs) are a significant source of BMP-2 [4].
VSMC migration from the vascular media to the intima is
pivotal in atherosclerosis, playing a central role in the genesis
of atherosclerotic plaques and restenotic lesions [5, 6].
VSMC migration is dependent upon cellular motility,
driven by cycles of actin polymerization, cellular adhesion,
and actin-myosin contraction. Myosins are a large family
of structurally diverse actin-dependent molecular motors.
All myosins utilize energy from ATP hydrolysis to generate
force for unidirectional movement along actin filaments
and are regarded as the most essential proteins driving
cellular migration [7–9]. The myosin superfamily consists
of both conventional and unconventional myosins [10, 11].
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Found in various organelles, unconventional myosins are
involved in RNA and protein transport, cellular movement,
signal transduction, cellular morphology maintenance, and
membrane trafficking [12].
The unconventional myosin Va is an actin-based motor
protein that transports intracellular cargos and can bundle
actin in vitro. The relationship and function of myosin
Va pertaining to cytoskeletal aspects, cellular morphology,
filopodia motility, and neurite extension have been reported
[13–15]. Recently, myosin Va was implicated in human cancer
dissemination [16, 17]. However, the function of myosin
Va within cardiovascular disease remains unclear. Whether
BMP-2 affects VSMCs migration via myosin Va, and if so, by
what mechanism, has never been determined. We investigate
the role of BMP-2 as a potential regulator of myosin Vain
VSMCs and dissect the involved underlying mechanisms.
2. Material and Methods
The study was carried out in accordance with the institu-
tional review board (IRB) approval. The study protocol was
approved by the institutional ethics committee and IRB of
the Beijing Anzhen Hospital, Affiliate of Capital Medical
University.
2.1. Cell Culture. Rat vascular smooth muscle cells were
primary-cultured via explant method and grown in RPMI-
1640 supplemented with 10% FBS, 100 𝜇g/mL penicillin,
100 𝜇g/mL streptomycin, and 2mM L-glutamine at 37∘C in
5% CO
2
atmosphere. rVSMCs were utilized for experimenta-
tion at passage 4–8 [18].
2.2. Recombinant Ads. ViralpAV.EX1d-CMV constructs con-
taining the rat BMP-2/myc/IRES/EGFP expressionwere from
Cyagen Biosciences Inc. (Guangzhou, China). HEK293 cells
were transfected by viruses via lipofectamine. The culture
medium supernatant was collected and purified by double
cesium chloride gradient ultracentrifugation [19].The viruses
were titrated by plaque assay in HEK293 cells. Physical
viral particle concentration (vp/mL) was determined spec-
trophotometrically by wavelength (260 nm) absorbance [20].
Viruses were stored at −80∘C until use.
2.3. CellMotility. Cells were plated on 60mmglassmicrowell
dishes and cultured overnight in RPMI-1640 containing
10% FBS. Cellular movements were monitored by Leica
SP5 inverted microscopy. Video images were collected
by CCD camera (model 3000; Leica) at 15-minute inter-
vals for 6 hours, digitized, and stored as image stacks
via Image J 1.41 software (National Institutes of Health,
http://rsb.info.nih.gov/ij/). Image stacks were converted to
QuickTimemovies. Nuclei positions were tracked to quantify
cell motility, and velocities were calculated in 𝜇mat 15-minute
intervals by the same software [21].
2.4. Boyden Chamber Assay. A 2 × 104 aliquot of each cell
type was plated onto a 24-well BioCoat Invasion Chamber
(BD Biosciences, USA) and cultured for 24 hours. Cells were
fixed bymethanol and stained by crystal violet. Five cell fields
were counted at approximately 40-fold magnification [22].
2.5. Wounding Assay. Cells were seeded in 35mm culture
dishes (density 2 × 105 cells per well). An incision was
made after 24 hours in the central region of confluence in
the culture dish. After an additional 48 hours, the dish was
carefully washed to remove detached cells. Fresh medium
was added. Cultures were observed at the time of incision
and after 48 hours. Phase-contrast microscopy pictures were
taken of 6 separate fields of the incised region. The distance
between two broad edges of cells was measured and analyzed
by Leica LAF software.
2.6. RNA Extraction, cRNA Preparation, and Gene Chip
Array. High quality rat RNA from BMP-2 infected VMSCs
and control cells were obtained by gel electrophoresis (18S
and 28S bands) and absorbance spectroscopy (240–320 nm).
Briefly, 8𝜇g of total RNA was reverse-transcribed by oligo
(dT) primer coupled to a T7 RNA polymerase binding
site. Biotinylated complementary RNA (cRNA) was then
synthesized from the resulting complementary DNA (cDNA)
via T7 polymerase. 25𝜇g of biotinylated cRNAwas randomly
sheared and hybridized for 16 hours to Affymetrix gene
chips.
The Affymetrix microarrays (Arabidopsis ATH1 genome
array) contain 22,810 probe sets, representing approximately
80% of the gene sequences on a single array. Labeling and
hybridization on theATH1microarrays (one sample per chip)
were performed according to manufacturer’s instructions
(http://www.affymetrix.com/estore/). The probe arrays were
scanned and further analyzed with Genespring software (ver
5.0; SiliconGenetics). Normalization per gene and per chip of
the log2 values was performed to allow comparison of three
independent replicates performed for each experiment set.
Genes were considered to be up- or downregulated if the ratio
between BMP-2 and control cells was, respectively, greater
than 2 or less than 0.5.
2.7. RT-PCR. Gene expression was measured by reverse
transcription kit (Promega, WI, USA). Briefly, after the RT of
3 𝜇g of total RNA, cDNA was synthesized. The RT products
were subjected to PCR with 2720 thermal cycles (abi) and
qRT-PCR via real-time PCR system Fast 7500 (abi.) with the
primer sets listed in Table 1(a). The cDNA of glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) served as internal
control. The semiquantitative RT-PCR consisted of 30 cycles
of 94∘C, 57.5∘C, and 72∘C (each for 30 seconds).
2.8. Western Blot Analysis. Cellular pellets were lysed by
RIPA buffer. 30 𝜇g of total protein samples was separated by
10% SDS-PAGE and electrophoretically transferred to PVDF
membranes. Membranes were blocked by 5% nonfat milk in
TPBS and incubated for 1 hour at room temperature with
primary antibody (see Table 1(b)). Secondary antibody HRP-
IgG was applied for 1 hour. After three additional TPBS
washes, signals were detected by enhanced chemilumines-
cence (Amersham Bioscience).
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Table 1: (a) PCR primer sequences. (b) Information regarding antibodies employed in Western analysis.
(a)
Gene name Sense Antisense Size (bp)
BMP-2 5󸀠-TATATGCTCGACCTGTACCG-3󸀠 5󸀠-CTTCCTGCATTTGTTCCCGA-3󸀠 247
Myosin Va 5󸀠-CACCTACGGAACCCTGACAT-3󸀠 5󸀠-TGCAAAGATGTGAGGGTCCA-3󸀠 243
Myosin Vb 5󸀠-GGCTGAACTAACCAAGGACT-3󸀠 5󸀠-GGCAACAAGCACAATTCCAC-3󸀠 256
Myosin Vc 5󸀠-GAAGATGGAAGGAAAGCAGG-3󸀠 5󸀠-TCCTCAAGATCCCTGTTTTC-3󸀠 255
SPP1 5󸀠-TGGCTTACGGACTGAGGTCA-3󸀠 5󸀠-GACCTCAGAAGATGAACTC-3󸀠 486
MGP 5󸀠-ATCCTGGCTGCGCTGGCCGTG-3󸀠 5󸀠-GAAGTAGCGGTTGTAGGCGGC-3󸀠 264
Sma22 5󸀠-AAGCCAGTGAAGGTGCCTGAG-3󸀠 5󸀠-TTGAAGGCCAATCACGTGCTT-3󸀠 311
Fstl1 5󸀠-GTGGCAGTAATGGCAAGAC-3󸀠 5󸀠-GTACTTGTCTAGGATCTCAC-3󸀠 260
GAPDH 5󸀠-AAGAAGGTGGTGAAGCAGG-3󸀠 5󸀠-ACCCTGTTGCTGTAGCCATA-3󸀠 197
(b)
Name Vender Cat. no. Species Dilution
BMP-2 Bioworld BS3473 Rabbit monoclonal IgG 1 : 500
MYO5a Sigma Sab2501441 Goat polyclonal IgG 1 : 1000
Smad1 Cell Signaling 9516 Rabbit monoclonal IgG 1 : 1000
Sm22 Epitomics S2112 Rabbit polyclonal IgG 1 : 1000
OPN Bioworld BS1264 Rabbit monoclonal IgG 1 : 1000
MGP Abgent Ap11953 Rabbit polyclonal IgG 1 : 200
FSTL1 Abcam Ab71548 Rabbit polyclonal IgG 1 : 1000
Actin Anbo C0124 Rabbit polyclonal IgG 1 : 5000
2.9. Knockdown of Myosin Va, Expression by siRNA. Three
specific sequences of small interfering RNA (siRNA) target-
ing different regions of rat MYO5a mRNA sequence were
designed (RiboBio Co., Ltd, China. 124171130126): siRNA-
1: 5󸀠-GGAGAAAGACCACAGATTA-3󸀠; siRNA-2: 5󸀠-GAA-
CCTGATTCTAGAACTA-3󸀠; siRNA-3: 5󸀠-GAAGCAATA-
TAGTGGAGAA-3󸀠. VSMCs were transfected after 48 hours
of culture with BMP-2 factor (250 𝜇g/mL). Lipofectamine in
transfection reagent (8 𝜇L) was added to 100 𝜇L OptiMEM
serum-free medium containing 2 nmol/L of each siRNA
oligo, incubated for 10 minutes, and added to the 6 cm plate
containing 2mL medium. After 72 hours, the efficacy of
myosin Va silencing (i.e., reduction of gene and protein
expression) was determined.
2.10. Immunofluorescence Analysis. Cells were seeded upon
cover slips at the bottomof culture dishes until subconfluence
and were then fixed with 5% acetic acid/95% ethanol (v/v) for
20 minutes. To block nonspecific reactions, 5% nonfat milk
was added for 30 minutes, and then anti-MYO5a polyclonal
antibody (1 : 250 dilutions in PBS) was administered at room
temperature for 1 hour. After washing, anti-goat IgG, FITC
fluorescein (1 : 800, Jackson) was added at room temperature
for 1 hour. DAPI (1 : 2000 in PBS; DABCO, Sigma) stained
for total nuclei. Imaging was performed by Leica SP5 laser
scanning confocal microscope.
2.11. [Ca2+]𝑖 Determination Assay. Cells were treated with
BMP-2 for 48 hours in dye-free media supplemented with
10% FBS, centrifuged prior to resuspension in calcium-
free modified Tyrode buffer (145mM NaCl, 5.6mM KCl,
100 𝜇M EGTA, 1.0mM MgCl
2
, 10mM glucose, and 5.0mM
HEPES, pH 7.2), and incubated for an additional 15 minutes.
Fluorescence was measured at room temperature via Leica
SP5 confocal imaging system. Two-dimensional confocal
images were taken at 1.5 second time intervals. Fluo-4 AM
(Dojindo, Japan) was excited at wavelength 488 nm, and
emission was detected at 515 nm. Changes in [Ca2+]i were
expressed as 𝑅 = 𝐹/𝐹
0
, where 𝑅 is resting fluorescence (𝐹)
divided by normalized fluorescence (𝐹
0
).
2.12. Statistical Analysis. All data are presented as mean ±
SD. The student’s two tailed 𝑡-test compared the difference
between two groups. 𝑃 values less than 0.05 were regarded
as statistically significant.
3. Results
3.1. Successful BMP-2 Overexpression by Adenoviral Trans-
fection Increases VSMC Motility. The adenoviral vector
pAV.EX1d-CMV with cloned construct myc/IRES/EGFP was
employed to overexpress BMP-2 in VSMCs. After purifica-
tion, adenoviral titer was amplified in the recombinant aden-
oviral pAV-EX1d system, reaching 108 transducing units/mL
(physical viral particle concentration vp/mL). AGFP pro-
tein detectable in coprimary culture of infected rat VSMCs
confirmed an expression ratio exceeding 90% (Figure 1(a)).
Single rat VSMC migration traced by time-lapse video
microscopy revealedBMP-2 overexpressingVSMCs are faster
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Figure 1: Adenoviral-mediated overexpression of BMP-2 and its effect upon cellular motility in both uni- and multicell populations. (a) GFP
expression of adenoviral transfected rat VSMCs assessed by confocal microscopy. Infection efficiency exceeds 90%. (b) Rat VSMCsmigration
traced by time-lapse video microscopy. Sixteen representative paths for each treatment originated from a common point, in stellate fashion.
Faster migration produced larger stars. Cellular motility was recorded on indicated substrates for 6 hours. (c) Movement assay: mean velocity
determined by time-lapse recording via ImageJ software. Overexpression of BMP-2 approximately doubled migratory capacity. (d) Boyden
chamber assay revealed increased cellular migration in adenoviral-transfected cells overexpressing BMP-2 compared to vector-only cells.
(e) Quantification of migration of BMP-2 overexpressing transfected cells; values represent the mean ± SD of independent experiments. (f)
Wounding assay, assessingmotility, and spread potential of a cellular population. VSMCs cells were virally-transfected to overexpress BMP-2.
Both at the time of cellular culture incision and 48 hours after, the state of wound closure was assessed by phase-contrast microscopy. Arrows
indicate distance from incision edges. ∗Student’s 𝑡-test: 𝑃 < 0.01 versus control.
than those infected by vector alone. Swifter VSMCmigration
resulted in larger spanning stellate “star” formations (Fig-
ure 1(b)). The average distance travelled by a moving single
cell in a six-hour observation period was confirmed every 15
minutes (BMP-2 travelled 0.24±0.2 𝜇mversus control: 0.12±
0.1 𝜇m, Figure 1(c)). Migratory cell mounts of rat VSMCs
overexpressing BMP-2 were compared to control cells in a
Boyden chamber assay (Figure 1(d)). BMP-2 overexpression
increased cellular intensity 130%, compared to vector alone
(𝑃 < 0.01, Figure 1(e)). The wounding assay demonstrated
BMP-2 influenced cellular population movement as well
within 48 hours (BMP-2: 93.3±17.8 𝜇mversus control: 43.7±
16.7 𝜇m, 𝑃 < 0.01, Figure 1(f)).
3.2. BMP-2 Increases Motility of Both Unicellular and Mul-
ticellular VSMC Populations in Dose-Dependent Manner.
VSMCs were treated with varying BMP-2 concentrations
(ranging from 50 to 500 ng/mL) via Boyden chamber for
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Figure 2: Dose-dependent effect of BMP-2 upon cellular motility. A Boyden chamber assay was performed upon rat VSMCs treated by
exogenous BMP-2 concentrations. ∗Student’s test: 𝑃 < 0.01 versus control.
48 hours. Figure 2 demonstrates VSMCs exhibit a dose-
dependent migratory effect in response to BMP-2 concen-
trations exceeding 100 ng/mL. Time-lapse video microscopy
and wounding assay, respectively, demonstrated unicellular
and multicellular VSMC populations responded in dose-
dependent manner to BMP-2 (Table 2).
3.3. Identification of Genes Regulated by BMP-2 Overex-
pression. To gain mechanistic insight concerning BMP-2-
mediated VSMC migration facilitation, microarray analyses
were performed to determine global gene expression changes
in BMP-2 overexpressing VSMCs. In VSMCs overexpressing
BMP-2, 554 genes were downregulated, and 437 genes were
upregulated. Not surprisingly, genes involved in the BMP
signaling pathway (such as Fstl1, Fstl3, Smad1, and Msx1)
were among those upregulated during BMP-2 overexpres-
sion. Although our gene chip array determined myosin Va
was consistently upregulated during BMP-2 overexpression,
myosin Vb and Vc were not detected. In addition, expression
of smooth muscle alpha-actin, a characterizing marker of
the systole phenotype, remained unchanged.ThemRNA and
protein levels ofOPNandMGP, characterizingmarkers of the
diastolic phenotype, were markedly altered (Figures 3(a) and
3(b)).
3.4. BMP-2 Overexpression Increases Myosin Va Expression.
Via RT-PCR, we determined adenoviral-mediated BMP-2
overexpression significantly increased myosin Va mRNA
sevenfold compared to control (Figure 4(a)), in a dose-
dependent manner (Figure 4(b)). We then confirmed BMP-
2 stimulation increased myosin Va protein expression by
BMP-2
MYO5a
MYO5b
MYO5c
OPN
MGP
SMa22
FstL1
GAPDH
Control BMP-2
(a)
BMP-2
MYO5a
Smad1
SMa22
OPN
MGP
FstL1
Actin
Control BMP-2
(b)
Figure 3: Gene chip array analysis demonstrating various gene
and protein levels after gene array analysis. (a) Gene expression
of myosin Va, myosin Vb, myosin Vc, OPN, MGP, SMa22, FSTL1,
and GAPDH via RT-PCR. (b) Protein levels of BMP-2, myosin Va,
Smad1, OPN, MGP, FSTL1, and pan-actin via Western analysis.
characterizing actin and myosin Va expressing VSMCs by
immunofluorescence analysis. Representative photographs in
Figure 4(c) display abundantly distributedmyosin Va protein
binding actin in the cytoplasm of VSMCs overexpressing
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Figure 4: Myosin Va expression regulated by BMP-2. (a) qRT-PCR analysis revealed mRNA upregulation of the myosin Va gene associated
with adenoviral-mediated BMP-2 overexpression in rat VSMCs. (b) Myosin Va expression reflects a dose-dependent response to BMP-2
administration. (c) Immunofluorescent assay characterizes actin and myosin Va expression. Myosin Va proteins were abundantly distributed
in the cytoplasm of cells binding closed actin in BMP-2 overexpressing VSMCs, compared to control (which manifested only weakly positive
signals).
BMP-2, compared to the weakly positive signals detected in
control cells. Together, these results strongly support aug-
mentedmyosin Va expression during BMP-2 overexpression.
3.5. siRNA-Mediated knockdown of VSMCMyosin Va Inhibits
Migration. We generated three myosin Va-specific siRNA
constructs. Compared to control or other generated siRNA
constructs, siRNA-construct-3 (henceforth termed siRNA-
3) significantly reduced the expression of both myosin Va
mRNA (Figure 5(a)) and protein (Figure 5(b)). siRNA-
mediated knockdown of myosin Va decreased its expression
in locations known to be detectable by immunofluorescence
assay in VSMCs simulated by BMP-2 (Figure 5(c)). We next
determined the functional consequence of myosin Va knock-
down in the setting of BMP-2 stimulation. VSMCs subjected
to myosin Va-knockdown by siRNA-3migrate significantly
slower compared to control or VSMCs subjected to siRNA
constructs 1 or 2 (Figures 5(d) and 5(e)).These results suggest
myosin Va may have significant role in BMP-2-mediated
acceleration of VSMC migration.
3.6. Erk1/2 Modulates Myosin Va Expression by BMP-2. The
signaling mechanisms responsible for the effects of BMP-2
overexpression upon VSMC migration are unclear. Software
(IPA, Ingenuity Sys) analysis revealed the relationship and
interaction between BMP-2, Erk1/2, myosin Va, and actin
Oxidative Medicine and Cellular Longevity 7
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Figure 5: Effects of siRNA-mediated knockdown of myosin Vain rat VSMCs subjected to BMP-2 (250 ng/mL). (a) qRT-PCR analyses,
demonstrating varying siRNA-mediated suppression of myosin Va mRNA expression. siRNA3 construct inhibited myosin Va mRNA
expression to 0.13-fold of scramble levels. (b)Western blot demonstrating siRNA-3 construct inhibits themostmyosinVa of all three generated
siRNA constructs. (c) Myosin Va expression, determined by immunofluorescence, inhibited by siRNA-3. (d) Unicellular motility detected
by Boyden chamber assay. (e) Multicellular population motility determined by wounding assay. Both (d) and (e) demonstrate that siRNA3
significantly inhibits migration compared to scramble control (unicellularmotility 144±25 versus 248±20 cells/well, multicellular population
17.5 ± 5 𝜇m versus 45.2 ± 4.8 𝜇m). ∗Student’s 𝑡-test: 𝑃 < 0.01 versus control.
Table 2: BMP-2 increased uni- and multicellular population motility.
Control 50 ng/mL 100 ng/mL 250 ng/mL 500 ng/mL
Signal cell movement distance (um/15min) 0.112 + 0.01 0.134 + 0.01 0.165 + 0.02 0.202 + 0.05 0.221 + 0.028
𝑃 value with ctrl 0.08 0.0021∗ 0.0003∗ 0.00032∗
Populations movement distance (um/24 h) 40.5 + 10.2 48.0 + 12.6 56.9 + 10.3 76.7 + 9.6 80.1 + 13.2
𝑃 value with ctrl 0.32 0.034∗ 0.0004∗ 0.0007∗
Compared to control group, Student’s test: ∗𝑃 < 0.01.
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(Figure 6(a)). We investigated the degree of Erk1/2 stimu-
lation in response to BMP-2 doses referenced in previous
studies [23]. VSMCs were either treated with exogenous
250 ng/mL BMP-2 for 48 hours or adenovirally transfected
to overexpress BMP-2. VSMCs were consequently exposed
to Erk1/2 inhibitor U0126. Erk1/2 activation was determined
byWestern blot. Erk1/2 inhibitor significantly increased BAD
protein production (typically downregulated by BMP-2) and
significantly decreased Bcl-xl and myosin Va expression
(typically upregulated by BMP-2) (Figure 6(b)). qRT-PCR
demonstrated upregulation of myosin Va gene mRNA in
rat VSMCs cells treated with 250 ng/mL BMP-2 for 48
hours, an effect blocked by 5 𝜇MU0126 (Figure 6(c)). U0126
attenuated BMP-2 augmented VSMC motility (Figure 6(d)).
Together, these results suggest Erk1/2 activity is essential for
modulating myosin Va expression by BMP-2.
3.7. BMP-2 Increases Intracellular [Ca2+]𝑖Oscillation. Cal-
cium (Ca2+) plays a pivotal role in physiological biochemistry,
acting as a second messenger in signal transduction path-
ways, involved with neurotransmitter release, all muscular
cell type contraction, and fertilization [24, 25].We investigate
the potential involvement of Ca2+ in the signalingmechanism
between BMP-2 and Erk1/2 by recording intracellular [Ca2+]i
oscillations within VSMCs. After loading the Ca+-sensitive
dye Fluo-4 AM, we monitored the time-dependent change
of [Ca2+]i within a colony’s individual cells. Figure 6(e)
demonstrates a representative VSMC colony, in which indi-
vidual cells exhibit spontaneous Ca2+ oscillation. Without
external Ca2+ supplementation, prolonged BMP-2 adminis-
tration activated a large transient increase in Ca2+, followed
by a burst of Ca2+ spikes. The average amplitude of sponta-
neous oscillations increased intracellular Ca2+ concentration
([Ca2+]i) (Figure 6(f)). Individual cell fluorescence (𝐹/𝐹
0
)
plotted as a function of time demonstrates oscillatory changes
in [Ca2+]i. Such [Ca2+]i oscillations significantly increased
in cells subjected to 250 ng/mL BMP-2 (Figure 6(g)). These
data suggest BMP-2-induced Ca2+ oscillations are generated
largely by a “cytosolic oscillator” inVSMCs. BMP-2-mediated
regulation of myosin Va may be modulated by Erk signaling
with Ca2+ involvement.
4. Discussion
We have made several important observations in the current
study. Firstly, we demonstrated BMP-2 overexpression in
VSMCs augments both unicellular and multicellular popula-
tion motility. Secondly, we demonstrated BMP-2 overexpres-
sion increases the expression of myosin Va but not myosin
Vb or Vc. Finally, we providemechanistic evidence of ERK1/2
involvement in the modulation of myosin Va expression by
BMP-2, with Ca2+ involvement.
Myosin Va directly assembles actin into antiparallel bun-
dles [26, 27] localized at the leading edge ofmembrane ruffles
[28]. A veritable actin-based motor protein, myosin Va,
functions as an intracellular vesicle and organelle transporter
and delivers cargo critical formaintaining cellularmovement,
thereby supporting cellular migration. Heretofore, whether
myosin Va regulates VSMC migration was unknown. In this
study, we demonstrate the abundant distribution of myosin
Va binding actin in the cytoplasm of BMP-2 overexpressing
VSMCs, compared to control cells. We also demonstrate
knockdown of myosin Va inhibits VSMCmotility, suggesting
myosin Va is requisite for VSMC migration. More detailed
analysis is required to elucidate how myosin Va specifically
affects cellular motility, but it is plausible myosin Va partic-
ipates in cell cytoskeleton reorganization, an essential event
driving cellular movement [13, 29].
We clearly demonstrate BMP-2 overexpression stimulates
cellular migration. We employed IPA software to analyze the
relationships and interactions among BMP-2, Erk1/2, Myosin
Va, and Ca2+, but previous reports have not revealed any
direct relationship between BMP-2 and myosin Va [30–32].
Erk1/2 inhibition not only blocked BMP-2-mediated down-
regulation of Bcl-xl protein production but also significantly
decreased expression of bothmyosinVa and BAD.MyosinVa
may mediate the functions of Bcl-xl by promoting islet cell
migration and invasion [15]. We have demonstrated BMP-
2 modulates myosin Va expression in VSMCs via Erk1/2
but cannot preclude the involvement of other contributory
factors regulating the expression of myosin Va, such as gene
regulatory elements like promoters and miRNAs. Further
work is necessary to fully characterize the myosin Va pro-
moter.
Spontaneous calcium oscillations occur in cells origi-
nating from excitable tissues of muscular, neuronal, and
embryonic stem origin [33–35]. Calcium is an important sec-
ondmessenger regulating both intracellular and extracellular
communications. The amplitude and duration of calcium
transients can promote the expression of specific genes.
Myosin Va is necessary for localization of IP3 receptors,
which may connect with intracellular Ca2+ [24, 25]. In
the current study, we observe the presence of spontaneous
[Ca2+]i oscillations in cultured VSMCs, further activated
in the presence of BMP-2. The Erk signaling pathway can
be stimulated by increased [Ca2+]i oscillations, augmenting
Erk1/2 phosphorylation [36, 37], supported by our results
(Figure 6). Additional studies specifically defining the precise
roles of Ca2+ as a second messenger in this system are
ongoing.
VSMCs can change phenotype in vivo depending upon
functional demands and can be contractile, proliferative,
migratory, and/or synthetic [38, 39]. We demonstrate that
BMP-2 overexpression increased expression of synthetic phe-
notypic markers OPN and MGP and decreased contractile
phenotypic marker SM22𝛼. The present study advances the
notion BMP-2 may modulate SMC phenotype towards a
synthetic state. Further studies are necessary to determine
whether Ca2+ oscillations may have phenotypic implications.
In summary, our study demonstrates BMP-2 enhances
VSMC migration via Erk1/2 signaling activation, which reg-
ulates myosin Va expression. Inhibition of BMP-2-induced
myosin Va expression may represent a potential future
therapeutic strategy attenuating atherosclerosis.
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Figure 6: BMP-2-mediated regulation of myosin Va may be modulated by Erk signaling with Ca2+ involvement. (a) IPA software analysis
of the relationships and interactions between BMP-2, Erk1/2, myosin Va, and actin. Although communication between the genes of these
proteins genes has previously been reported, heretofore, a direct interaction between BMP-2 and myosin Va was not clarified. (b) Western
demonstrates the presence of key proteins involved with myosin Va and Erk signaling in the lysates of rat VSMCs either adenovirally
transfected to overexpress BMP-2 or treated with exogenous BMP-2 (250 ng/mL) for 48 hours. (c) qRT-PCR analysis demonstrating myosin
Va genemRNAwas upregulated in VSMCs treated with 250 ng/mL BMP2 for 48 hours and downregulated in the presence of Erk1/2 inhibitor
U0126 (dose 5 𝜇M). (d)Migration of VSMCs subjected to identical conditions was detected by Boyden chamber assay (BMP-2+ alone: 253±29
versus BMP-2+/U0126+: 176 ± 11). (e) Oscillatory increase of intracellular Ca2+ concentration ([Ca2+]i) within individual cells of the colony.
Chronological image sequence goes from left to right at 1.5-second intervals over 5 minutes. (f) Oscillations exhibited a mean interval of
intracellular Ca2+ concentration (BMP-2 concentration 250 ng/mL, 𝑛 = 18). (g) Fluorescence (𝐹/𝐹
0
) of individual cells, values represent
mean ± SD; ∗Student’s 𝑡-test: 𝑃 < 0.01).
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